MedTrace Logo

Coexistence HBsAg/HBcAC, Clinical Characterístics & Outcomes

NCT05446532 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2025-05-31

No results posted yet for this study

Summary

HBV infection is a dynamic process with complex interactions between virus replication and the host's immune response. The appearance of anti-HBs after HBV infection generally indicates recovery and immunity to HBV1 infection. However, there are several published studies that describe the coexistence of the marker of chronic infection (HBsAg +) and the marker of functional cure (HBsAc +). There are contradictory studies on whether the coexistence of HBsAg/HBsAc implies a different clinical course.

Conditions

Sponsors & Collaborators

  • Hospital Mutua de Terrassa

    collaborator OTHER

  • Consorci Sanitari de Terrassa

    collaborator OTHER

  • Hospital Universitario La Fe

    collaborator OTHER

  • Germans Trias i Pujol Hospital

    collaborator OTHER

  • Corporacion Parc Tauli

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-15
Primary Completion
2022-10-31
Completion
2022-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05446532 on ClinicalTrials.gov